This case concerns infringement by Glenmark on Novartis’ SPC 300451 for eltrombopag (marketed as Revolade®). Novartis sought urgent relief after Glenmark included its generic "Eltrombopag Glenmark" product in the Dutch...more
In this note, we will discuss the latest decisions on the merits from the Dutch patent court on the matter of plausibility and inventive step. These were handed down in two cases (BMS v Sandoz and BMS v Teva) on 30 October...more
11/15/2024
/ Appeals ,
EU ,
Inventions ,
Netherlands ,
Patent Applications ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Technology ,
Teva v Sandoz ,
Unified Patent Court